<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wikman H</submitter><funding>European Research Council</funding><pagination>R49</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3446383</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(2)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>With the improvement of therapeutic options for the treatment of breast cancer, the development of brain metastases has become a major limitation to life expectancy in many patients. Therefore, our aim was to identify molecular markers associated with the development of brain metastases in breast cancer.&lt;h4>Methods&lt;/h4>Patterns of chromosomal aberrations in primary breast tumors and brain metastases were compared with array-comparative genetic hybridization (CGH). The most significant region was further characterized in more detail by microsatellite and gene-expression analysis, and finally, the possible target gene was screened for mutations.&lt;h4>Results&lt;/h4>The array CGH results showed that brain metastases, in general, display similar chromosomal aberrations as do pr</pubmed_abstract><journal>Breast cancer research : BCR</journal><pubmed_title>Relevance of PTEN loss in brain metastasis formation in breast cancer patients.</pubmed_title><pmcid>PMC3446383</pmcid><funding_grant_id>269081</funding_grant_id><pubmed_authors>Uslar L</pubmed_authors><pubmed_authors>Benner C</pubmed_authors><pubmed_authors>Pantel K</pubmed_authors><pubmed_authors>Kemming D</pubmed_authors><pubmed_authors>Zapatka M</pubmed_authors><pubmed_authors>Westphal M</pubmed_authors><pubmed_authors>Muller V</pubmed_authors><pubmed_authors>Hohensee I</pubmed_authors><pubmed_authors>Wikman H</pubmed_authors><pubmed_authors>Sauter G</pubmed_authors><pubmed_authors>Glatzel M</pubmed_authors><pubmed_authors>Ylstra B</pubmed_authors><pubmed_authors>Wrage M</pubmed_authors><pubmed_authors>Eylmann K</pubmed_authors><pubmed_authors>Lamszus K</pubmed_authors><pubmed_authors>Detels N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Relevance of PTEN loss in brain metastasis formation in breast cancer patients.</name><description>&lt;h4>Introduction&lt;/h4>With the improvement of therapeutic options for the treatment of breast cancer, the development of brain metastases has become a major limitation to life expectancy in many patients. Therefore, our aim was to identify molecular markers associated with the development of brain metastases in breast cancer.&lt;h4>Methods&lt;/h4>Patterns of chromosomal aberrations in primary breast tumors and brain metastases were compared with array-comparative genetic hybridization (CGH). The most significant region was further characterized in more detail by microsatellite and gene-expression analysis, and finally, the possible target gene was screened for mutations.&lt;h4>Results&lt;/h4>The array CGH results showed that brain metastases, in general, display similar chromosomal aberrations as do pr</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 Mar</publication><modification>2026-04-07T13:59:05.654Z</modification><creation>2019-03-27T00:58:08Z</creation></dates><accession>S-EPMC3446383</accession><cross_references><pubmed>22429330</pubmed><doi>10.1186/bcr3150</doi></cross_references></HashMap>